Congenital factor X deficiencies with a defect only or predominantly in the extrinsic or in the intrinsic system: A critical evaluation

American Journal of Hematology

Volumn 83, Issue 8, 2008, Pages 668-671

  Girolami, Antonio ^a   Scarparo, Pamela ^a   Scandellari, Raffaella ^a   Allemand, Emanuele ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 10;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; EXON; FAMILY; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IMMUNOASSAY; MOLECULAR BIOLOGY; PRIORITY JOURNAL;

EXONS; FACTOR X DEFICIENCY; FAMILY; HUMANS; MUTATION; PHENOTYPE;

EID: 49149108816     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21207     Document Type: Article

References (29)

1. Denson KW. Abnormal forms of factor X. Lancet 1969;2:256.
2. Girolami A. Tentative and updated classification of factor X variants. Acta Haematol 1986;75:58-59.
3. Fair DS, Edgington Th S. Heterogeneity of hereditary and acquired factor X deficiencies by combined immunological and functional analysis. Br J Haematol 1985;59:235-248.
4. Cooper DN, Miller DS, Wacey A, et al. Inherited factor X deficiency: Molecular genetics and pathophysiology. Thromb Haemost 1997;78:161-172.
5. Perry DJ. Factor X and its deficiency states. Haemophilia 1997;3:159-172.
6. Uprichard J, Perry DJ. Factor X deficiency. Blood Rev 2002;16:97-110.
7. Girolami A, Molaro G, Lazzarin M, Scarpa R. Una nuova coagulopatia emor-ragica congenita probabilmente dovuta alla presenza di un Fattore X abnorme. Min Med 1969;60:4939-4949.
8. Girolami A, Molaro G, Lazzarin M, et al. A new congenital haematologic condition due to the presence of an abnormal factor X (factor X friuli). A study of large kindred. Br J Haematol 1970;19:179-192.
9. Parkin JD, Madaras F, Sweet B, Castaldi PA. A further inherited variant of coagulation factor X. Aust N Z J Med 1974;4:561-564.
10. Girolami A, Vicariotto M, Ruzza G, et al. Factor X padua: A new congenital factor X abnormality. Acta Haematol 1985;73:31-36.
11. Nora RE, Bell WR, Noe DA, Sholar PW. Normal partial thromboplastin time and associated spindle cell thymoma. Ann J Med 1985;79:122-126.
12. Bertina RM, Alder Kamp GI, de Nogy F. A variant of factor X that is defective only in extrinsic coagulation. Thromb Haemost 1981;46:88a.
13. Girolami A, Vianello F, Cabrio L, Lombardi AM. A new mutation (Arg251Trp) in the Ca2+ binding site of factor X protease domain appears to be responsible for the defect in the extrinsic pathway activation of factor X padua. Clin Appl Thromb Haemost 2004;10:5-8.
14. Reddy SV, Zhou Z, Rao KI, et al. Molecular characterization of human factor X San Antonio. Blood 1989;74:1486-1490.
15. Watzke HH, Lechner K, Roberts HR, et al. Molecular defect (Gla+14 - Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg"). J Biol Chem 1990;265:11982-11989.
16. Al-Hilali A, Lawson A, Fair A. Family with factor X variant defective only in factor VII activation (Riyadh). Ann Saud Med 1989;9:48-51.
17. Al-Hilali A, Wulff K, Abdel-Razeq H, et al. Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly. Thromb Haemost 2007;97:542-545.
18. Sun P, Hata J, Bauer J, et al. A functional factor X deficiency. Am J Haematol 1995;48:1-4.
19. Zama T, Murata M, Watanabe R, et al. A family with hereditary factor X deficiency with a point mutation Gla32 to Gln in the Gla domain (factor X Tokyo). Br J Haematol 1999;106:809-811.
20. Forberg E, Huhmann I, Jimenez-Boj E, Watzke HH. The impact of Glu102Lys on the factor X function in a patient with a doubly homozygous factor X deficiency (Gla14Lys and Glu102Lys). Thromb Haemost 2000;85:234-238.
21. red FX deficiency. Thromb Haemost 2002;88:236-241.
22. Greenberg DL, Davie EW. Blood coagulation factors: Their complementary DNAs, genes, and expression. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, editors. Haemostasis and Thrombosis, 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. pp 21.
23. De Stefano V, Leone G, Ferrelli R, et al. Factor X roma: A congenital factor X variant defective at different degrees in the intrinsic and extrinsic activation. Br J Haematol 1998;69:387-391.
24. Odom MW, Leone G, De Stefano V, et al. Five novel point mutations: Two causing haemophilia B and three causing factor X deficiency. Mol Cell Probes 1994;8:63-65.
25. Iijima K, Murakami M, Kimura O, et al. A dysfunctional factor X (factor X kurayoshi) with a substitution of Arg139 for Ser at the carboxyl-terminus of the light chain. Thromb Res 2001;101:311-316.
26. Nair SC, Baidya S, Sukumaran D, et al. Hereditary disfunctional factor X- Is that passovoy factor? J Thromb Haemost 2007;5(suppl. 2):PM195.
27. Telfer TP, Denson KW, Wright DR. A new congenital defect. Br J Haematol 1956;2:306-312.
28. Hougie C, Barrow EM, Graham JB. Stuart clotting defect. Segregation of a hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest 1957; 36:485-496.
29. Bachmann F, Duckert F, Fluckiger P. Über einen meuartigen Kongenitalen Gerinnungsdefect (Mangel an Stuart Factor). Thromb Diath Haemorrh 1957; 1:87-92.